Receptors in neurodegenerative diseases

Pharmaceutica Acta Helvetiae

Volumn 74, Issue 2-3, 2000, Pages 247-251

  Froestl, Wolfgang ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Brain derived neurotrophic factor (BDNF); Ciliary neurotrophic factor (CNTF); Death receptors; Glial cell line derived neurotrophic factor (GNTF); Insulin like growth factor I (IGF 1); Nerve growth factor (NGF)

Indexed keywords

1 (3,3 DIMETHYL 1,2 DIOXOPENTYL) 2 PYRROLIDINECARBOXYLIC ACID 3 (3 PYRIDYL)PROPYL ESTER; ADAPTOR PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE; CASPASE 9; CILIARY NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LETEPRINIM; MESSENGER RNA; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN 4; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG; XALIPRODEN;

APOPTOSIS; CONFERENCE PAPER; DRUG DESIGN; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; HIPPOCAMPUS; HUMAN; NERVE DEGENERATION; NONHUMAN; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION;

ANIMALS; HUMANS; NEURODEGENERATIVE DISEASES; NEUROPEPTIDES; RECEPTORS, NEUROPEPTIDE;

EID: 0034126167     PISSN: 00316865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-6865(99)00035-7     Document Type: Conference Paper

References (46)

1. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival (Review). Science. 281:1998;1322-1326.
2. Altar C.A. Neurotrophins and depression (Review). Trends Pharmacol. Sci. 20:1999;59-61.
3. Altar C.A., DiStefano P.S. Neurotrophin trafficking by anterograde transport (Review). Trends Neurosci. 21:1998;433-437.
4. Amgen-Regeneron Brain-derived neurotrophic factor (BDNF, rhBDNF). Drugs Future. 23:1998;1031-1033.
5. Aravind L., Dixit V.M., Koonin E.V. The domains of death: evolution of the apoptosis machinery. Trends Biochem. Sci. 24:1999;47-53.
6. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation (Review). Science. 281:1998;1305-1308.
7. Cass, W.A., Kearns, C.M., Gash, D.M., 1998. Protective and regenerative properties of GDNF in the central nervous system. In: Mattson, M.P. (Ed.), Neuroprotective Signal Transduction. Humana Press, Totowa, pp. 145-161.
8. Chao M.V., Hempstead B.L. p75 and Trk: a two-receptor system (Review). Trends Neurosci. 18:1995;321-326.
9. Di Marco A., Gloaguen I., Graziani R., Paonessa G., Saggio I., Hudson K.R., Laufer R. Identification of ciliary neurotrophic factor (CNTF) residues essential for leukemia inhibitory factor receptor binding and generation of CNTF receptor antagonists. Proc. Natl. Acad. Sci. U.S.A. 93:1996;9247-9252.
10. Doré S., Kar S., Quirion R. Insulin-like growth factor I protects and rescues hippocampal neurons against β-amyloid- and human amylin-induced toxicity. Proc. Natl. Acad. Sci. U.S.A. 94:1997;4772-4777.
11. Doré S., Kar S., Quirion R. Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases (Review). Trends Neurosci. 20:1997;326-331.
12. Eigenbrot C., Gerber N. X-ray structure of glial cell-derived neurotrophic factor at 1.9 Å resolution and implications for receptor binding. Nature Struct. Biol. 4:1997;435-438.
13. Elmér E., Kokaia Z., Kokaia M., Carnahan J., Nawa H., Lindvall O. Dynamic changes of brain-derived neurotrophic factor protein levels in the rat forebrain after single and recurring kindling-induced seizures. Neuroscience. 83:1998;351-362.
14. Emerich D.F., Winn S.R., Hantraye P.M., Peschanski M., Chen E.-Y., Chu Y., McDermott P., Baetge E.E., Kordower J.H. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature. 386:1997;395-399.
15. Fischer W., Wictorin K., Björklund A., Williams L.R., Varon S., Gage F.H. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature. 329:1987;65-68.
16. Harper S., Bilsland J., Young L., Bristow L., Boyce S., Mason G., Rigby M., Hewson L., Smith D., O'Donnell R., O'Connor D., Hill R.G., Evans D., Swain C., Williams B., Hefti F. Analysis of the neurotrophic effects of GPI-1046 on neuron survival and regeneration in culture and in vivo. Neuroscience. 88:1999;257-267.
17. Hefti F. Neurotrophic factor therapy for nervous system degenerative diseases (Review). J. Neurobiol. 25:1994;1418-1435.
18. Hefti, F., Denton, T.L., Knusel, B., Lapchak, P.A., 1993. Neurotrophic factors: what are they and what are they doing? In: Loughlin, S.E., Fallow, J.H. (Eds.), Neurotrophic Factors. Academic Press, San Diego, pp. 25-49.
19. Ibáñez C.F. Emerging themes in structural biology of neurotrophic factors (Review). Trends Neurosci. 21:1998;438-444.
20. Jing S., Wen D., Yu Y., Holst P.L., Luo Y., Fang M., Tamir R., Antonio L., Hu Z., Cupples R., Louis J.-C., Hu S., Altrock B.W., Fox G.M. GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF. Cell. 85:1996;1113-1124.
21. Jönhagen M.E., Nordberg A., Amberla K., Bäckman L., Ebendal T., Meyerson B., Olson L., Seiger Å., Shigeta M., Theodorsson E., Viitanen M., Winblad B., Wahlund L.-O. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dementia Geriatr. Cognit. Disord. 9:1998;246-257.
22. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
23. Kinloch R.A., Treherne J.M., Furness L.M., Hajimohamadreza I. The pharmacology of apoptosis (Review). Trends Pharmacol. Sci. 20:1999;35-42.
24. Kumar S., Colussi P.A. Prodomains-adaptors-oligomerization: the pursuit of caspase activation in apoptosis. Trend Biochem. Sci. 24:1999;1-4.
25. Lamb P., Tapley P., Rosen J. Biochemical approaches to discovering modulators of the JAK-STAT pathway. Drug Discovery Today. 3:1998;122-130.
26. Lessmann V. Neurotrophin-dependent modulation of glutamatergic synaptic transmission in the mammalian CNS (Review). Gen. Pharmacol. 31:1998;667-674.
27. Levi-Montalcini R., Hamburger V. A diffusible agent of mouse sarcoma, producing hyperplasia of sympathetic ganglia and hyper-neurotization of viscera in the chick embryo. J. Exp. Zool. 123:1953;233-287.
28. Lindvall O., Kokaia Z., Bengzon J., Elmér E., Kokaia M. Neurotrophins and brain insults (Review). Trends Neurosci. 17:1994;490-496.
29. Mason I. The GDNF receptor: recent progress and unanswered questions (Review). Mol. Cell. Neurosci. 8:1996;112-119.
30. McDonald N.Q., Lapatto R., Murray-Rust J., Gunning J., Wlodawer A., Blundell T.L. New protein fold revealed by a 2.3 Å resolution crystal structure of nerve growth factor. Nature. 354:1991;411-414.
31. McDonald N.Q., Panayotatos N., Hendrickson W.A. Crystal structure of dimeric human ciliary neurotrophic factor determined by MAD phasing. EMBO J. 14:1995;2689-2699.
32. Olson L. Neurotrophins in neurodegenerative disease: theoretical issues and clinical trials (Commentary). Neurochem. Int. 25:1994;1-3.
33. Penn R.D., Kroin J.S., York M.M., Cedarbaum J.M. Intrathecal ciliary neurotrophic factor delivery for treatment of amyotropic lateral sclerosis (Phase I trial). Neurosurgery. 40:1997;94-100.
34. Robertson K., Mason I. The GDNF-RET signalling partnership (Comment). Trends Genet. 13:1997;1-3.
35. Rubin R., Baserga R. Insulin-like growth factor-I receptor. Laboratory Investigation. 73:1995;311-331.
36. Schneider P., Thome M., Burns K., Bodmer J.-L., Hofmann K., Kataoka T., Holler N., Tschopp J. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB. Immunity. 7:1997;831-836.
37. Schulze-Osthoff K., Ferrari D., Los M., Wesselborg S., Peter M.E. Apoptosis signaling by death receptors (Review). Eur. J. Biochem. 254:1998;439-459.
38. Springer, J.E., Kitzman, P.H., 1998. Neuroprotective strategies involving the neurotrophins and their signaling pathways. In: Mattson, M.P. (Ed.), Neuroprotective Signal Transduction. Humana Press, Totowa, NJ, pp. 1-21.
39. Stahl N., Yancopoulos G.D. The tripartite CNTF receptor complex: activation and signaling involves components shared with other cytokines. J. Neurobiol. 25:1994;1454-1466.
40. Steiner J.P., Hamilton G.S., Ross D.T., Valentine H.L., Guo H., Connolly M.A., Liang S., Ramsey C., Li J.-H.J., Huang W., Howorth P., Soni R., Fuller M., Sauer H., Nowotnik A.C., Suzdak P.D. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc. Natl. Acad. Sci. U.S.A. 94:1997;2019-2024.
41. Thoenen H. Neurotrophins and neuronal plasticity. Science. 270:1995;593-598.
42. Thome M., Hofmann K., Burns K., Martinon F., Bodmer J.-L., Mattmann C., Tschopp J. Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Current Biology. 8:1998;885-888.
43. Thornberry N.A., Lazebnik Y. Caspases: enemies within (Review). Science. 281:1998;1312-1316.
44. Tschopp J., Irmler M., Thome M. Inhibition of Fas death signals by FLIPs. Curr. Opin. Immunol. 10:1998;552-558.
45. Ware, C.F., Santee, S., Glass, A., 1998. Tumor necrosis factor-related ligands and receptors. In: Thomson, A.W. (Ed.), The Cytokine Handbook, 3rd edn. Academic Press, San Diego, pp. 549-592.
46. Wood P.L. Small molecule inducers of neurotrophic function (Review). IDrugs. 1:1998;452-455.